Differential expression of epidermal growth factor-related proteins in human colorectal tumors
about
Dual roles of Cripto as a ligand and coreceptor in the nodal signaling pathway.Regulation of ERBB3/HER3 signaling in cancerCytosolic phospholipase A2-alpha associates with plasma membrane, endoplasmic reticulum and nuclear membrane in glomerular epithelial cellsAntisense oligonucleotides against microRNA-21 reduced the proliferation and migration of human colon carcinoma cellsEpithelial-mesenchymal transition markers and HER3 expression are predictors of elisidepsin treatment response in breast and pancreatic cancer cell linesNon ionising radiation as a non chemical strategy in regenerative medicine: Ca(2+)-ICR "In Vitro" effect on neuronal differentiation and tumorigenicity modulation in NT2 cellsTransforming growth factor-alpha prevents detachment-induced inhibition of c-Src kinase activity, Bcl-XL down-regulation, and apoptosis of intestinal epithelial cellsProneoplastic effects of PGE2 mediated by EP4 receptor in colorectal cancer.Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma.Cell surface molecules and their prognostic values in assessing colorectal carcinomas.Cripto haploinsufficiency affects in vivo colon tumor developmentAmphiregulin promotes intestinal epithelial regeneration: roles of intestinal subepithelial myofibroblasts.Colorectum cell-derived growth factor (CRDGF) is homologous to amphiregulin, a member of the epidermal growth factor family.The role of HER3, the unpretentious member of the HER family, in cancer biology and cancer therapeutics.Interleukin 1 alpha and tumor necrosis factor alpha stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial cells.Phenotypic variation resulting from a deficiency of epidermal growth factor receptor in mice is caused by extensive genetic heterogeneity that can be genetically and molecularly partitionedAmphiregulin as an autocrine growth factor for c-Ha-ras- and c-erbB-2-transformed human mammary epithelial cells.Extracellular superoxide dismutase regulates the expression of small gtpase regulatory proteins GEFs, GAPs, and GDI.Roles for transforming growth factor-alpha in gastric physiology and pathophysiologyPET and MRI of metastatic peritoneal and pulmonary colorectal cancer in mice with human epidermal growth factor receptor 1-targeted 89Zr-labeled panitumumab.Interleukin-6 and interleukin-6 soluble receptor regulate proliferation of normal, human papillomavirus-immortalized, and carcinoma-derived cervical cells in vitroExpression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas.Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancerGRP78 Protein Expression as Prognostic Values in Neoadjuvant Chemoradiotherapy and Laparoscopic Surgery for Locally Advanced Rectal CancerDemonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells.Meprinα transactivates the epidermal growth factor receptor (EGFR) via ligand shedding, thereby enhancing colorectal cancer cell proliferation and migrationRegulation of apoptosis during homeostasis and disease in the intestinal epithelium.HER3 over-expression and overall survival in gastrointestinal cancersExpression of epidermal growth factor family gene members in early mouse development.Mechanisms of resistance to EGFR targeted therapies.FAT1: a potential target for monoclonal antibody therapy in colon cancer.The ERBB3 receptor in cancer and cancer gene therapyThe Crosstalk of PTGS2 and EGF Signaling Pathways in Colorectal CancerEpidermal growth factor receptor signaling is required for microadenoma formation in the mouse azoxymethane model of colonic carcinogenesis.Tumor-specific apoptosis caused by deletion of the ERBB3 pseudo-kinase in mouse intestinal epithelium.Clinicopathological and biological significance of cripto overexpression in human colon cancerRadiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and TherapyThe promise of anti-ErbB3 monoclonals as new cancer therapeuticsTargeting HER3 using mono- and bispecific antibodies or alternative scaffolds.HER3 comes of age: new insights into its functions and role in signaling, tumor biology, and cancer therapy.
P2860
Q24299162-8C3BA2C1-E027-4943-9EC2-9AF03257E21BQ27024334-1396C35A-B65A-4E76-B164-B8EA4451AF50Q28345075-4E80FD33-BDB1-4CD7-96C3-EDB72F3CE4FFQ28384798-2FE829D9-B6E9-4897-849E-6255CF613E30Q28484892-DC89F8CA-1389-4051-99AD-D8E803177CE3Q28486085-5B97EF4A-AEBC-4983-94B1-3D1FF59F3829Q28580989-0F141E85-5E01-45D5-99D1-F7CB5EBF6372Q33475171-8F5B029F-8C18-42DC-9CE5-7D7966ED4695Q33500375-B4866E0D-62ED-4462-915D-C6A16CB9ABCFQ33818072-D8C169AF-C7C4-41CB-B303-FCFF11F33843Q33836502-05A6EE69-BE53-475E-89DE-29FE03E1E0F5Q34132456-7617E1B9-D81F-49B0-B007-4E6093437140Q34239204-6AE4DF62-CFE7-4723-9F94-91BAD861112CQ34349389-B6FA94C5-F3BF-4734-A499-5972849D7B5EQ34508216-D1ABB535-883E-409F-9FAB-B291B2B6CBF7Q34645600-8C781254-7C24-4DD2-ABB8-BD355BCF1544Q35134719-1CE10594-042F-483D-BD3D-0C5D380356D2Q35159451-48AE963C-DAC9-4D3E-B6AD-646E8D4740C0Q35242603-A964EB39-17DD-4EE3-A4C4-110C1BBEFFD7Q35655093-761C3688-392E-4BF1-971E-6D6CFD356F07Q35795051-6E5AEC3A-F2A8-451E-B668-38B598411CC6Q35978421-7C003CB7-DE54-471B-A329-745A50236E2EQ36040592-BCBE6DC8-2EC8-4CE2-92D8-DE69FA124EB9Q36187080-EECF2D6D-B2A0-41B7-B54A-67ADF21C2197Q36205683-0D526366-E652-4694-BBFA-9159B7793696Q36318836-6FBC462E-817B-4C3C-8B60-F8EB9C50CF8BQ36467014-26703B48-AB20-4A5E-B8C9-009D2DF07BF2Q36619051-1AACE89B-C92D-49AF-B5A7-D9137AC48253Q36718607-3335F242-5067-497A-B63A-DB6F0A293E6CQ36887721-19D30A06-406D-4BC0-96D1-A80894029FD2Q37061340-1B11F3EF-0597-41A2-A18D-D997EA6E0513Q37135372-6CD0CADB-0D67-4382-BF1D-C13BA5D55CC2Q37148157-7C1FB4DC-7B26-4DE8-8E43-C79BC1E87330Q37250403-9AF473E9-08F7-4FB8-9760-E3DA75B145BCQ37328476-CE4BDA14-5C83-425C-A4D2-3D43E260A772Q37408842-07A8D320-7F01-4502-A210-FE21AA36AEE8Q37689802-78755871-D62E-4E69-8775-9BCFA5E980F9Q38034347-8CD2A542-A77F-432B-8849-499372A678D7Q38929801-B2E0D30B-8424-4DC1-8328-D0D68F24C3C9Q39368710-8256E5E8-6ED3-4BCA-9A4C-3DC82E764932
P2860
Differential expression of epidermal growth factor-related proteins in human colorectal tumors
description
1991 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
article publié dans les Procee ...... f the United States of America
@fr
artículu científicu espublizáu en 1991
@ast
im September 1991 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1991/09/01)
@sk
vědecký článek publikovaný v roce 1991
@cs
wetenschappelijk artikel (gepubliceerd op 1991/09/01)
@nl
наукова стаття, опублікована у вересні 1991
@uk
name
Differential expression of epi ...... ins in human colorectal tumors
@ast
Differential expression of epi ...... ins in human colorectal tumors
@en
Differential expression of epi ...... ins in human colorectal tumors
@nl
type
label
Differential expression of epi ...... ins in human colorectal tumors
@ast
Differential expression of epi ...... ins in human colorectal tumors
@en
Differential expression of epi ...... ins in human colorectal tumors
@nl
prefLabel
Differential expression of epi ...... ins in human colorectal tumors
@ast
Differential expression of epi ...... ins in human colorectal tumors
@en
Differential expression of epi ...... ins in human colorectal tumors
@nl
P2093
P2860
P3181
P356
P1476
Differential expression of epi ...... ins in human colorectal tumors
@en
P2093
D. S. Salomon
F. Ciardiello
G. D. Plowman
G. J. Todaro
J. Garrigues
M. G. Persico
P2860
P304
P3181
P356
10.1073/PNAS.88.17.7792
P407
P577
1991-09-01T00:00:00Z